PublishYou are now at: Home » Purchase » Other »

medical treatment

Original
Quantity:
Price:
Packing:
Area: AsiaChina
Valid until: Never Expire
Updated on: 2014-12-26 11:18
Hits: 37
Quote
Company Details
You are not logged in. Please log in to view contact details
After registering for free as a member, you can...
Supply and demand information Promote their products
The establishment of corporate shops Do business online
Not a member, Register Now
 
 
Details
Hemotrans Co., Ltd
Year Established: 2003 
Registration Capital: 2 million baht
Managing Director: Ms. Wanna Sae-Ooy
In DSC set up Hemotrans Co., Ltd., its affiliated Thai company to undertake trials of Dextran-Hemoglobin in Bangkok. Thailand is one of Asia’s leaders in the field of Health Care, with an annual income of one billion dollars (USD) from foreign patients who travel to Thailand specifically for medical treatment. To support this growing Health Care sector, the Thai government has announced several funding programs to attract international biotechnology projects. Moreover, it has adopted a flexible regulatory strategy that is designed to reduce the costs and time frames of the regulatory process. Since October 2004, DSC has developed a growing network of government agencies, hospitals, clinicians, pharmaceutical companies and universities to assist in the project. DSC has signed a research and development contract with Hong Kong University of Science and Technology. Under that agreement, Dr. Wong and his staff are conducting further research and producing product for animal testing. Currently, DSC is negotiating strategic partnerships with several biotechnology companies that will meet needs of production, marketing and distribution in South-East Asia, the Middle East and Africa.

 
More»RelatedPurchase

[ Purchase Search ]  [ Add to Favourite ]  [ Publicity ]  [ Print ]  [ Violation Report ]  [ Close ]

 
Home | Contact us | About Us | Site Map | Guestbook | RSS | 增值电信业务经营许可证: 辽B2-20150174